What is STERIS's EBITDA margin?

Latest reported EBITDA margin for STERIS (STE) is 22.62% as of the trailing twelve months (TTM) ending March 31, 2026.

How has STERIS EBITDA margin changed year-over-year?

STERIS (STE) EBITDA margin changed −6.3 percentage points year-over-year on the latest annual filing.

When did STERIS EBITDA margin hit its highest annual value?

STERIS EBITDA margin reached its highest annual value of 29.63% in 2023.

What was STERIS EBITDA margin in 2025?

STERIS (STE) EBITDA margin in 2025 was 24.89%.

What was STERIS EBITDA margin in 2026?

STERIS (STE) EBITDA margin in 2026 was 18.56%.

STERIS (STE) EBITDA Margin — Annual & Quarterly %

TTM

22.6%

YoY change

−6.32pp

Trough year (1992)

1.6%

Peak year (2023)

29.6%

EBITDA Margin history chart for STERIS (STE) from 1991 to 2026

Latest: 18.6%

EBITDA Margin change chart for STERIS (STE) from 1991 to 2026

Latest: −6.32pp

EBITDA Margin history table for STERIS (STE) from 1991 to 2026


2026	18.6%	-6.32pp	Mar 31, 2026	May 29, 2026
2025	24.9%	-2.60pp	Mar 31, 2025	May 29, 2025
2024	27.5%	-2.14pp	Mar 31, 2024	May 29, 2024
2023	29.6%	+5.73pp	Mar 31, 2023	May 26, 2023
2022	23.9%	-1.01pp	Mar 31, 2022	May 31, 2022
2021	24.9%	+0.61pp	Mar 31, 2021	May 28, 2021
2020	24.3%	+1.29pp	Mar 31, 2020	May 29, 2020
2019	23.0%	+0.71pp	Mar 31, 2019	May 30, 2019
2018	22.3%	+6.32pp	Mar 31, 2018	Mar 31, 2018
2017	16.0%	-0.03pp	Mar 31, 2017	Mar 31, 2017
2016	16.0%	-1.26pp	Mar 31, 2016	Mar 31, 2016
2015	17.3%	-0.16pp	Mar 31, 2015	Mar 31, 2015
2014	17.4%	-3.33pp	Mar 31, 2014	Mar 31, 2014
2013	20.8%	+0.43pp	Mar 31, 2013	Mar 31, 2013
2012	20.3%	+8.72pp	Mar 31, 2012	Mar 31, 2012
2011	11.6%	-9.16pp	Mar 31, 2011	Mar 31, 2011
2010	20.8%	+2.61pp	Mar 31, 2010	Mar 31, 2010
2009	18.2%	+2.21pp	Mar 31, 2009	Mar 31, 2009
2008	16.0%	-1.13pp	Mar 31, 2008	Mar 31, 2008
2007	17.1%	+0.45pp	Mar 31, 2007	Mar 31, 2007
2006	16.6%	-1.17pp	Mar 31, 2006	Mar 31, 2006
2005	17.8%	+0.60pp	Mar 31, 2005	Mar 31, 2005
2004	17.2%	-0.53pp	Mar 31, 2004	Mar 31, 2004
2003	17.7%	+3.01pp	Mar 31, 2003	Mar 31, 2003
2002	14.7%	+0.05pp	Mar 31, 2002	Mar 31, 2002
2001	14.7%	+5.54pp	Mar 31, 2001	Mar 31, 2001
2000	9.1%	-12.16pp	Mar 31, 2000	Mar 31, 2000
1999	21.3%	+2.25pp	Mar 31, 1999	Mar 31, 1999
1998	19.0%	+1.86pp	Mar 31, 1998	Mar 31, 1998
1997	17.2%	+0.42pp	Mar 31, 1997	Mar 31, 1997
1996	16.7%	+1.30pp	Mar 31, 1996	Mar 31, 1996
1995	15.4%	-3.55pp	Mar 31, 1995	Mar 31, 1995
1994	19.0%	+8.88pp	Mar 31, 1994	Mar 31, 1994
1993	10.1%	+8.56pp	Mar 31, 1993	Mar 31, 1993
1992	1.6%	-3.00pp	Mar 31, 1992	Mar 31, 1992
1991	4.5%	—	Mar 31, 1991	Mar 31, 1991

202618.6%-6.32pp
202524.9%-2.60pp
202427.5%-2.14pp
202329.6%+5.73pp
202223.9%-1.01pp
202124.9%+0.61pp
202024.3%+1.29pp
201923.0%+0.71pp
201822.3%+6.32pp
201716.0%-0.03pp
201616.0%-1.26pp
201517.3%-0.16pp
201417.4%-3.33pp
201320.8%+0.43pp
201220.3%+8.72pp
201111.6%-9.16pp
201020.8%+2.61pp
200918.2%+2.21pp
200816.0%-1.13pp
200717.1%+0.45pp
200616.6%-1.17pp
200517.8%+0.60pp
200417.2%-0.53pp
200317.7%+3.01pp
200214.7%+0.05pp
200114.7%+5.54pp
20009.1%-12.16pp
199921.3%+2.25pp
199819.0%+1.86pp
199717.2%+0.42pp
199616.7%+1.30pp
199515.4%-3.55pp
199419.0%+8.88pp
199310.1%+8.56pp
19921.6%-3.00pp
19914.5%—

EBITDA Margin values are taken from STERIS's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at STERIS (STE)

According to STERIS's latest reported financial statements, the company's latest reported EBITDA margin is 22.6%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending March 31, 2026 (reported May 29, 2026). Chart and table below cover the full reported history back to 1991.

As of the 2026 fiscal year, STERIS (STE) reported EBITDA margin of 18.56% – contracted 6.3 percentage points year-over-year.

The highest annual EBITDA margin of 29.63% was reported in 2023. The lowest in the available history was 1.55% in 1992.

STERIS EBITDA Margin by Year

STERIS EBITDA Margin 2026: 18.6%

STERIS EBITDA margin in 2026 was 18.56%, contracted 6.3 percentage points from 2025.

STERIS EBITDA Margin 2025: 24.9%

2025's EBITDA margin for STERIS came in at 24.89%, contracted 2.6 percentage points from 2024.

STERIS EBITDA Margin 2024: 27.5%

STERIS posted EBITDA margin of 27.49% in 2024, contracted 2.1 percentage points from 2023.

STERIS EBITDA Margin 2023: 29.6%

In 2023, STERIS reported EBITDA margin of 29.63%, expanded 5.7 percentage points from 2022. This figure represents the highest annual value in the available history.

STERIS EBITDA Margin 2022: 23.9%

STERIS EBITDA margin in 2022 was 23.90%.

See more financial history for STERIS (STE).

Sector peers by EBITDA Margin

Healthcare peers of STERIS (STE), ranked by their latest EBITDA margin


Novo Nordisk (NVO)	55.4%
Amgen (AMGN)	46.6%
Eli Lilly (LLY)	45.9%
Merck & Co. (MRK)	34.6%
AstraZeneca (AZN)	33.9%
Johnson & Johnson (JNJ)	30.3%
AbbVie (ABBV)	26.9%
UnitedHealth Group (UNH)	5.1%

Frequently asked questions

STERIS (STE) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation